FHIR IG Statistics: ValueSet/England-HighRiskReferralReasonScreening

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source

{
  "resourceType": "ValueSet",
  "id": "England-HighRiskReferralReasonScreening",
  "url": "https://fhir.nhs.uk/England/ValueSet/England-HighRiskReferralReasonScreening",
  "version": "0.1.0",
  "name": "EnglandHighRiskReferralReasonScreening",
  "title": "England High Risk Referral Reason Screening",
  "status": "draft",
  "experimental": false,
  "date": "2024-11-22",
  "publisher": "NHS England",
  "contact": [
    {
      "name": "NHS England",
      "telecom": [
        {
          "system": "email",
          "value": "interoperabilityteam@nhs.net",
          "use": "work",
          "rank": 1
        }
      ]
    }
  ],
  "description": "A ValueSet used to indicate which higher risk codes are associated with a patient. The codes and their description are datasets definition from the Breast Screening Service(BS-Select).",
  "copyright": "Copyright © 2024+ NHS England Licensed under the Apache License, Version 2.0 (the \"License\"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an \"AS IS\" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html.",
  "expansion": {
    "timestamp": "2024-11-22T12:00:00+00:00",
    "contains": [
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "AT-heterozygotes",
        "display": "A-T Heterozygotes"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "AT-homozygotes",
        "display": "A-T Homozygotes"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "BRCA-risk",
        "display": "BRCA1/BRCA2/PALB2 (8% 10-Year Risk)"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "BRCA-tested",
        "display": "BRCA1/BRCA2/PALB2 Tested"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "HR-gene-untested",
        "display": "HR Gene Untested"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "other-gene-mutations",
        "display": "Other Gene Mutations"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "radiotherapy-below-30",
        "display": "Radiotherapy Below Aged 30"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "radiotherapy-lower",
        "display": "Radiotherapy To Breast Tissue Aged 10-19"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "radiotherapy-upper",
        "display": "Radiotherapy To Breast Tissue Aged 20-35"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "risk-equivalent",
        "display": "Risk Equivalent, Not Tested"
      },
      {
        "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason",
        "code": "TP53",
        "display": "TP53 (Li-Fraumeni) Syndrome"
      }
    ]
  }
}